Dr. House

Dr. House
Dr. House

Thursday, April 5, 2018

Overweight Kids Who Lose Excess Weight In Childhood May Also Lose Higher Risk Of Type 2 Diabetes

reports that while “being overweight as a child increases the risk of type 2 diabetes in adulthood,” research published in The New England Journal of Medicine “shows that the extra risk disappears if that excess weight is lost by age 13 and kept off in early adulthood.” The study “used registry data to track weights at ages seven, 13 and in early adulthood to look for correlations to diet-dependent diabetes by age 30 to 60” in approximately 62,500 Danish men. https://www.reuters.com/article/us-health-kids-overweight/heavy-kids-who-normalize-weight-in-childhood-can-avoid-extra-diabetes-risk-idUSKCN1HB32I

Wednesday, April 4, 2018

Rare Superbugs May Be More Common Than Previously Believed

reports bacteria that carry extremely rare types of antibiotic resistance are more common in the US than previously thought, according to a report from the Centers for Disease Control and Prevention. Researchers with the Antibiotic Resistance Laboratory Network conducted nationwide testing in 2017 to identify such superbugs. CBS News (4/3, Welch) reports on its website that the researchers found “221 instances of unusual resistance,” such as “carbapenem-resistant Enterobacteriaceae (CRE).” According to the CBS, “unusual resistance” is defined as bacteria “that cannot be killed by all or most antibiotics; are currently uncommon in the US; or have specific genes that allow them to spread their resistance to other germs.” https://www.cbsnews.com/news/antibiotic-resistant-nightmare-bacteria-a-growing-threat-in-the-u-s/

FDA Orders Kratom Recall for Salmonella Manufacturer refused to cooperate in voluntary process

Kratom is an increasingly popular herbal product, mostly imported from Southeast Asia, with opioid-like psychoactive properties. It is widely promoted for treating pain and symptoms of opioid withdrawal. The FDA said it had asked Triangle on March 30 to initiate a recall, which the firm ignored. The agency issued another notice to Triangle the following day, ordering the company to stop distributing its kratom products. When that notice also didn't elicit a response, the agency said, on Monday it followed through with a mandatory recall order. Other firms have complied with FDA requests to recall their kratom products, the agency said. https://www.medpagetoday.com/publichealthpolicy/publichealth/72126?xid=nl_mpt_DHE_2018-04-04&eun=g721819d0r&pos=4&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%202018-04-04&utm_term=Daily%20Headlines%20-%20Active%20User%20-%20180%20days

Tuesday, April 3, 2018

Hospitalization Rates For Diabetic Ketoacidosis Are On The Rise

reports that CDC data indicate that “hospitalization rates for diabetic ketoacidosis (DKA) are on the rise.” Following “a nearly 10-year period of slight decline, age-adjusted rates of hospitalization for the life-threatening, preventable diabetes complication increased nearly 55% between 2009 and 2014.” The findings were published in the CDC’s Morbidity and Mortality Weekly Report. https://login.medscape.com/login/sso/getlogin?urlCache=aHR0cHM6Ly93d3cubWVkc2NhcGUuY29tL3ZpZXdhcnRpY2xlLzg5NDY3Mg==&ac=401

Health Groups Sue FDA for Delayed E-Cig Regulation

https://www.medpagetoday.com/pulmonology/smoking/72021?xid=nl_mpt_special_reports_2018-04-03%20&uun=g721819d0r5883165u

Monday, April 2, 2018

New Diabetes Subgroups May Improve Treatment Outcomes,

reported that “clustering patients into 5 subgroups may be beneficial for identifying those at risk for diabetic complications,” according to a study published in the Lancet Diabetes & Endocrinology. The investigators wrote, “the results of our study suggest that this new clustering of patients with adult-onset diabetes is superior to the classic diabetes classification because it identifies patients at high risk of diabetic complications at diagnosis and provides information about underlying disease mechanisms, thereby guiding choice of therapy.” https://www.endocrinologyadvisor.com/type-2-diabetes-advisor/diabetes-subgroups-novel-treatment-prevention-diabetic-complications/article/753602/

“Hospital-At-Home” Care Helps Some Patients Avoid “Germy And Noisy” Hospitals.

reported on “hospital-at-home” scenarios where physicians and nurses come to patients’ home twice a day and perform any needed tests or bloodwork to help patients avoid “germy and noisy” hospitals and reduce labor costs. A wireless patch can be affixed to a patient’s skin to track vital signs and send a steady stream of data to the hospital. While such systems have been in place in other countries, “a key obstacle” in the US is getting health insurers to pay for it. https://www.washingtonpost.com/national/health-science/hospitals-are-germy-noisy-places-some-acutely-ill-patients-are-getting-treated-at-home-instead/2018/03/30/5fcb5006-2155-11e8-badd-7c9f29a55815_story.html